Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0129 | 0.0188 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0015 | 0.0296 | 0.3033 |
Schistosoma mansoni | tar DNA-binding protein | 0.0075 | 0.2095 | 0.3546 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.0012 | 0.0193 | 0.011 |
Toxoplasma gondii | small ubiquitin family modifier, putative | 0.0036 | 0.0932 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0054 | 0.1468 | 0.3545 |
Entamoeba histolytica | ubiquitin like protein | 0.0036 | 0.0932 | 1 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0025 | 0.0591 | 0.0406 |
Loa Loa (eye worm) | TAR-binding protein | 0.0075 | 0.2095 | 0.5058 |
Loa Loa (eye worm) | RecQ helicase | 0.0028 | 0.0695 | 0.1677 |
Brugia malayi | MH1 domain containing protein | 0.001 | 0.0129 | 0.0316 |
Plasmodium falciparum | nicotinamide/nicotinic acid mononucleotide adenylyltransferase | 0.0337 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0054 | 0.1468 | 0.2331 |
Schistosoma mansoni | smad | 0.001 | 0.0129 | 0.0188 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0193 | 0.1896 |
Plasmodium falciparum | small ubiquitin-related modifier | 0.0036 | 0.0932 | 0.0754 |
Trypanosoma cruzi | small ubiquitin protein, putative | 0.0036 | 0.0932 | 1 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.001 | 0.0129 | 0.0313 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0054 | 0.1468 | 0.2331 |
Brugia malayi | Ubiquitin-like protein SMT3 | 0.0036 | 0.0932 | 0.2279 |
Mycobacterium ulcerans | bifunctional nicotinate-nucleotide adenylyltransferase NadD/hypothetical protein | 0.0337 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0143 | 0.4142 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0054 | 0.1468 | 0.359 |
Echinococcus multilocularis | ubiquitin | 0.0013 | 0.0222 | 0.0161 |
Plasmodium vivax | small ubiquitin-related modifier, putative | 0.0036 | 0.0932 | 0.092 |
Loa Loa (eye worm) | hypothetical protein | 0.0006 | 0.002 | 0.0047 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.001 | 0.0129 | 0.0188 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0193 | 0.0471 |
Brugia malayi | hypothetical protein | 0.0013 | 0.0222 | 0.0543 |
Trypanosoma brucei | small ubiquitin-related modifier | 0.0036 | 0.0932 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0129 | 0.0188 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0193 | 0.0471 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.0012 | 0.0193 | 0.011 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0015 | 0.0296 | 0.1049 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0222 | 0.0536 |
Trypanosoma cruzi | small ubiquitin protein, putative | 0.0036 | 0.0932 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0054 | 0.1468 | 0.2331 |
Echinococcus granulosus | geminin | 0.02 | 0.5873 | 1 |
Brugia malayi | MH2 domain containing protein | 0.001 | 0.0129 | 0.0316 |
Echinococcus multilocularis | Small ubiquitin modifier 2 | 0.0036 | 0.0932 | 0.1397 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0054 | 0.1468 | 0.2475 |
Brugia malayi | MH2 domain containing protein | 0.001 | 0.0129 | 0.0316 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.0012 | 0.0193 | 0.011 |
Entamoeba histolytica | recQ family helicase, putative | 0.0015 | 0.0296 | 0.3085 |
Echinococcus granulosus | bloom syndrome protein | 0.0028 | 0.0695 | 0.0984 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0411 | 0.4288 |
Brugia malayi | RNA binding protein | 0.0075 | 0.2095 | 0.5122 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0012 | 0.0193 | 0.1896 |
Brugia malayi | TAR-binding protein | 0.0075 | 0.2095 | 0.5122 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0141 | 0.4091 | 0.9875 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0054 | 0.1468 | 0.2331 |
Leishmania major | small ubiquitin protein, putative | 0.0036 | 0.0932 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0075 | 0.2095 | 0.5058 |
Mycobacterium tuberculosis | Probable nicotinate-nucleotide adenylyltransferase NadD (deamido-NAD(+) pyrophosphorylase) (deamido-NAD(+) diphosphorylase) (nic | 0.0337 | 1 | 0.5 |
Giardia lamblia | Sentrin | 0.0036 | 0.0932 | 1 |
Plasmodium vivax | nicotinate-nucleotide adenylyltransferase, putative | 0.0337 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.02 | 0.5873 | 1 |
Schistosoma mansoni | DNA helicase recq5 | 0.0012 | 0.0193 | 0.0296 |
Echinococcus granulosus | ubiquitin | 0.0013 | 0.0222 | 0.0161 |
Entamoeba histolytica | hypothetical protein | 0.0013 | 0.0222 | 0.2275 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0028 | 0.0695 | 0.1698 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0012 | 0.0193 | 0.0465 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.001 | 0.0129 | 0.0313 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.0019 | 0.0418 | 0.0405 |
Echinococcus granulosus | Small ubiquitin modifier 2 | 0.0036 | 0.0932 | 0.1397 |
Schistosoma mansoni | tar DNA-binding protein | 0.0075 | 0.2095 | 0.3546 |
Brugia malayi | MH2 domain containing protein | 0.0141 | 0.4091 | 1 |
Loa Loa (eye worm) | SMO-1 protein | 0.0036 | 0.0932 | 0.225 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0129 | 0.0188 |
Loa Loa (eye worm) | RNA binding protein | 0.0075 | 0.2095 | 0.5058 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0028 | 0.0695 | 0.6655 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0028 | 0.0695 | 0.6655 |
Schistosoma mansoni | hypothetical protein | 0.02 | 0.5873 | 1 |
Schistosoma mansoni | DNA helicase recq1 | 0.0012 | 0.0193 | 0.0296 |
Brugia malayi | Smad1 | 0.001 | 0.0129 | 0.0316 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0036 | 0.0932 | 1 |
Schistosoma mansoni | Smad4 | 0.001 | 0.0129 | 0.0188 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0022 | 0.0515 | 0.0846 |
Treponema pallidum | hypothetical protein | 0.0337 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0075 | 0.2095 | 0.3546 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0141 | 0.4091 | 0.9875 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0054 | 0.1468 | 0.2475 |
Schistosoma mansoni | hypothetical protein | 0.02 | 0.5873 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0193 | 0.0465 |
Schistosoma mansoni | tar DNA-binding protein | 0.0075 | 0.2095 | 0.3546 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0075 | 0.2095 | 0.5122 |
Echinococcus multilocularis | bloom syndrome protein | 0.0028 | 0.0695 | 0.0984 |
Echinococcus granulosus | tar DNA binding protein | 0.0075 | 0.2095 | 0.3423 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.0012 | 0.0193 | 0.011 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0054 | 0.1468 | 0.2475 |
Loa Loa (eye worm) | Smad1 | 0.001 | 0.0129 | 0.0313 |
Schistosoma mansoni | tar DNA-binding protein | 0.0075 | 0.2095 | 0.3546 |
Echinococcus multilocularis | tar DNA binding protein | 0.0075 | 0.2095 | 0.3423 |
Brugia malayi | MH1 domain containing protein | 0.001 | 0.0129 | 0.0316 |
Onchocerca volvulus | 0.0013 | 0.0222 | 0.5 | |
Schistosoma mansoni | ubiquitin-like protein sumo/smt3-related | 0.0036 | 0.0932 | 0.1559 |
Entamoeba histolytica | recQ family DNA helicase | 0.0006 | 0.002 | 0.0074 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AUC (ADMET) | = 53.4 ug.hr/ml | AUC (0 to infinity) in CD-1 mouse plasma at 40 mg/kg, po | ChEMBL. | 22148391 |
AUC (ADMET) | = 169 ug.hr/ml | AUC (0 to infinity) in CD-1 mouse lung at 40 mg/kg, po | ChEMBL. | 22148391 |
Cmax (ADMET) | = 2.5 ug ml-1 | Cmax in CD-1 mouse plasma at 40 mg/kg, po | ChEMBL. | 22148391 |
Cmax (ADMET) | = 11.7 ug ml-1 | Cmax in CD-1 mouse lung at 40 mg/kg, po | ChEMBL. | 22148391 |
FC (functional) | = 0.92 | Antimicrobial activity against Mycobacterium tuberculosis infected in chronic BALB/c mouse infection model assessed as fold reduction in lung CFU at 30 mg/kg, po administered daily 5 days a week for 8 weeks starting 50 days post-infection | ChEMBL. | 22148391 |
FC (functional) | = 5.2 | Antimicrobial activity against Mycobacterium tuberculosis infected in BALB/c mouse assessed as fold reduction in lung CFU at 100 mg/kg, po administered 11 days after post infection qd for 5 days per week for 3 weeks relative to PA-824 | ChEMBL. | 22148391 |
IC50 (binding) | > 30 uM | Inhibition of human Erg expressed in HEK293 cells by FAST patch clamp analysis | ChEMBL. | 22148391 |
MIC (functional) | = 0.033 uM | Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring pFCA-lux AB gene measured under aerobic condition after 8 days by luminescence analysis | ChEMBL. | 22148391 |
MIC (functional) | = 1.1 uM | Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring pFCA-lux AB gene measured under anaerobic condition after 11 days by luminescence analysis | ChEMBL. | 22148391 |
PPB (ADMET) | = 91 % | Plasma protein binding in human at 10 uM | ChEMBL. | 22148391 |
Stability (ADMET) | = 85 % | Metabolic stability of the compound in CD-1 mouse liver microsomes assessed as compound remaining after 1 hr | ChEMBL. | 22148391 |
T1/2 (ADMET) | = 10.5 hr | Half life in CD-1 mouse lung at 40 mg/kg, po | ChEMBL. | 22148391 |
T1/2 (ADMET) | = 10.5 hr | Half life in CD-1 mouse plasma at 40 mg/kg, po | ChEMBL. | 22148391 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.